A Word From our Experts

Artboard – 1 1

Trust.med Registry Launch

By Tom Cooper | Sep 26, 2023

The registry is a catalog of drug product identifiers paired with manufacturer contact information. It’s searchable by National Drug Code (NDC) or Global Trade Item Number (GTIN). We developed it to enhance communication on the drug supply chain.

Read More
The World Wide Web 2

Supply Chain Communication

By Lloyd Mager | May 19, 2023

The US drug supply chain regulation envisions a secure Electronic Drug Distribution system that requires authorized trading partners to access and interact with it. So, what exactly is this system and what are your responsibilities within it?

Read More
Aggregation and Exceptions 3

Beyond DSCSA: Aggregation and Exceptions

By Lloyd Mager | Mar 8, 2023

DSCSA does not mandate aggregation. Does that mean you shouldn’t aggregate your data?

Of course not! Since everyone, including manufacturers, will rely on the practice of inference. Aggregation is in fact necessary for interoperable trade in the drug supply chain.

What most manufacturers and distributors don’t yet realize is that aggregated information will become a key component of their exception handling strategy and their ability to demonstrate control.

Read More
BLOG 3 Must Knows

DSCSA for Pharmacies: 3 Must Knows

By Daniel Kraciun | Jan 17, 2023

DSCSA for Pharmacies: 3 Must Knows Data Exchange | Partner Verification | Tracing Requests This is the year. The year the pharmaceutical supply chain must comply with the FDA’s Drug Supply Chain Security Act (DSCSA). These requirements must be met in order to operate within the US Drug Supply Chain. As the primary touchpoint between … Read more

Read More
DSCSA Dilema

The Drug Manufacturer’s DSCSA Dilemma

By Daniel Kraciun | Oct 19, 2022

A decade’s worth of time has expired since the Drug Supply Chain Security Act (DSCSA) was passed to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. This November marks the start of the 12 month countdown requiring pharmaceutical trading partners to comply with the law. As time quickly slips away, trading partners are still left with unanswered questions and serious operational risks if found to be non-compliant by November 27, 2023.

Read More
Resolvers 1

Resolvers: The Internet’s Address Book

By John Winkler | Sep 13, 2022

What exactly does it mean when someone says they have configured a “resolver?” This quick post will explain the concept of a resolver, how Trust.med is using resolvers to address DSCSA compliance, and how you can start using resolvers today…

Read More
All For One

All for One, One for All: Interoperable Ecosystems for DSCSA

By Lloyd Mager | Aug 31, 2022

The industry will need the ability to collaborate with each other and connect to relevant distributed data sets within an interoperable ecosystem by November 2023…

Read More
Sharing Should Be Easy 3

Sharing Should Be Easy: Have You Achieved Interoperability for DSCSA Compliance?

By Lloyd Mager | Aug 9, 2022

Interoperability is a characteristic of an ability to work with others. DSCSA requires that ATPs be able to work among themselves to exchange product information as needed for the purpose of transaction, product verification or trace for various suspect/illegitimate product reasons, and for enhancement of industry recall mechanisms…

Read More

Talk with Us.

Complete the form and we will connect you with a GS1 DSCSA certified member of our team.